SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer

Solange Peters, Roy Herbst, Hidehito Horinouchi, Luis Paz-Ares, Melissa Johnson, Benjamin J. Solomon, Mahmut Gumus, Mustafa Erman, Igor Bondarenko, Dong-Wan Kim, Enriqueta Felip, Alessandro Morabito, Maciej Bryl, Laszlo Urban, Kaname Nosaki, Martin Reck, Raymond Meng, Chipman Stroud, Palak Kundu, Xiaohui Wen, Namrata S. Patil, Meilin Huang, Sarah Troutman, Christina Matheny, Byoung Chul Cho

Open source

DOI
10.1200/jco-25-02777
Published
2026-09-01
Container
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-25-02777,
  title = {SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer},
  author = {Solange Peters and Roy Herbst and Hidehito Horinouchi and Luis Paz-Ares and Melissa Johnson and Benjamin J. Solomon and Mahmut Gumus and Mustafa Erman and Igor Bondarenko and Dong-Wan Kim and Enriqueta Felip and Alessandro Morabito and Maciej Bryl and Laszlo Urban and Kaname Nosaki and Martin Reck and Raymond Meng and Chipman Stroud and Palak Kundu and Xiaohui Wen and Namrata S. Patil and Meilin Huang and Sarah Troutman and Christina Matheny and Byoung Chul Cho},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-25-02777},
  url = {https://doi.org/10.1200/jco-25-02777}
}

RIS

TY  - JOUR
TI  - SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer
AU  - Solange Peters
AU  - Roy Herbst
AU  - Hidehito Horinouchi
AU  - Luis Paz-Ares
AU  - Melissa Johnson
AU  - Benjamin J. Solomon
AU  - Mahmut Gumus
AU  - Mustafa Erman
AU  - Igor Bondarenko
AU  - Dong-Wan Kim
AU  - Enriqueta Felip
AU  - Alessandro Morabito
AU  - Maciej Bryl
AU  - Laszlo Urban
AU  - Kaname Nosaki
AU  - Martin Reck
AU  - Raymond Meng
AU  - Chipman Stroud
AU  - Palak Kundu
AU  - Xiaohui Wen
AU  - Namrata S. Patil
AU  - Meilin Huang
AU  - Sarah Troutman
AU  - Christina Matheny
AU  - Byoung Chul Cho
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-25-02777
UR  - https://doi.org/10.1200/jco-25-02777
ER  - 

APA

Peters, S., Herbst, R., Horinouchi, H., Paz-Ares, L., Johnson, M., Solomon, B. J., Gumus, M., Erman, M., Bondarenko, I., Kim, D., Felip, E., Morabito, A., Bryl, M., Urban, L., Nosaki, K., Reck, M., Meng, R., Stroud, C., Kundu, P., Wen, X., Patil, N. S., Huang, M., Troutman, S., Matheny, C., & Cho, B. C. (2026). SKYSCRAPER-01: Tiragolumab in Combination With Atezolizumab in Previously Untreated PD-L1–High, Locally Advanced, Unresectable or Metastatic Non–Small Cell Lung Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02777

Source records